Evidence map›Paper›PMID 29847650›Full record

ArticleInvestigative ophthalmology & visual science2018

Generation and Proteome Profiling of PBMC-Originated, iPSC-Derived Corneal Endothelial Cells.

Muhammad Ali, Shahid Y Khan, Shivakumar Vasanth, Mariya R Ahmed, Ruiqiang Chen, Chan Hyun Na, Jason J Thomson, Caihong Qiu, John D Gottsch, S Amer Riazuddin

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Biomedical Application of MSCs in Corneal Regeneration and Repair.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. iPSC-Derived Corneal Endothelial Cells.Handbook of experimental pharmacology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tracking the important role ofOncology letters · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Muhammad AliThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Shahid Y KhanThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Shivakumar VasanthThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Mariya R AhmedThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Ruiqiang ChenDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Chan Hyun NaDepartment of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Jason J ThomsonYale Stem Cell Center, Yale University School of Medicine, New Haven, Connecticut, United States.
Caihong QiuYale Stem Cell Center, Yale University School of Medicine, New Haven, Connecticut, United States.
John D GottschThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
S Amer RiazuddinThe Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Johns Hopkins University · USJohns Hopkins Medicine · USYale University · US

Funding

Genetics of Fuchs Corneal DystrophyR01EY028538 · NEI · JOHNS HOPKINS UNIVERSITY · PI GOTTSCH, JOHN D · 2018 to 2022
$2.0M
NEI NIH HHS R01 EY028538
6 · The paper itself

Abstract

Purpose: Corneal endothelial cells (CECs) are critical in maintaining clarity of the cornea. This study was initiated to develop peripheral blood mononuclear cell (PBMC)-originated, induced pluripotent stem cell (iPSC)-derived CECs. Methods: We isolated PBMCs and programmed the mononuclear cells to generate iPSCs, which were differentiated to CECs through the neural crest cells (NCCs). The morphology of differentiating iPSCs was examined at regular intervals by phase contrast microscopy. In parallel, the expression of pluripotent and corneal endothelium (CE)-associated markers was investigated by quantitative real-time PCR (qRT-PCR). The molecular architecture of the iPSC-derived CECs and human corneal endothelium (hCE) was examined by mass spectrometry-based proteome sequencing. Results: The PBMC-originated, iPSC-derived CECs were tightly adherent, exhibiting a hexagonal-like shape, one of the cardinal characteristics of CECs. The CE-associated markers expressed at significantly higher levels in iPSC-derived CECs at days 13, 20, and 30 compared with their respective levels in iPSCs. It is of importance that only residual expression levels of pluripotency markers were detected in iPSC-derived CECs. Cryopreservation of iPSC-derived CECs did not affect the tight adherence of CECs and their hexagonal-like shape while expressing high levels of CE-associated markers. Mass spectrometry-based proteome sequencing identified 10,575 proteins in the iPSC-derived CEC proteome. In parallel, we completed proteome profiling of the hCE identifying 6345 proteins. Of these, 5763 proteins were identified in the iPSC-derived CECs, suggesting that 90.82% of the hCE proteome overlaps with the iPSC-derived CEC proteome. Conclusions: We have successfully developed a personalized approach to generate CECs that closely mimic the molecular architecture of the hCE. To the best of our knowledge, this is the first report describing the development of PBMC-originated, iPSC-derived CECs.

Indexed as

AgedCell DifferentiationCells, CulturedCryopreservationEmbryonic Stem CellsEndothelium, CornealFlow CytometryGene Expression ProfilingGenetic MarkersHumansImmunohistochemistryInduced Pluripotent Stem CellsLeukocytes, MononuclearMaleMass SpectrometryMicroscopy, Phase-ContrastGenetic MarkersProteome

Identifiers

PMID29847650
PMCPMC5957521
OpenAlexW2805531988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.